How is treatment determined in renal cell carcinoma?
The future of drug development: broader signatures in precision medicine, beyond genomics
Cell cycle-dependent resistance or sensitivity to drugs and the importance of MITF genes in melanoma
The cancer immunogram: a framework for improved melanoma treatment
The open questions surrounding immunotherapy and targeted therapy in lung cancer